NCT04037423

Brief Summary

The main goals of EuroPE-CDT is to assess the currently applied catheter-directed treatment (CTD) techniques and strategies in pulmonary embolism (PE) patients and to determine the short term efficacy and safety of this invasive procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
145

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 4, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 22, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 30, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

2.6 years

First QC Date

July 22, 2019

Last Update Submit

July 29, 2023

Conditions

Acute Pulmonary Embolism

Outcome Measures

Primary Outcomes (1)

  • Survival

    Short-time follow-up

    30 days after the procedure

Secondary Outcomes (1)

  • Complications

    During hospitalisation (estimated 10 days)

Study Arms (1)

PE patients treated with CDT

Acute pulmonary embolism patients undergoing catheter-directed embolectomy.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospitalized patients.

You may qualify if:

  • acute pulmonary embolism
  • catheter-directed embolectomy

You may not qualify if:

  • appropriate data not available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Internal Medicine & Cardiology with the Centre for Management of Venous Thromboembolic Disease, Medical University of Warsaw

Warsaw, 02-005, Poland

Location

Study Officials

  • Piotr Purszczyk, prof.

    Medical University of Warsaw

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 22, 2019

First Posted

July 30, 2019

Study Start

June 4, 2019

Primary Completion

December 31, 2021

Study Completion

March 31, 2022

Last Updated

August 1, 2023

Record last verified: 2023-07

Locations

PL(1)